| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |